No Data
No Data
Windtree Announces Istaroxime Presentation By Cardiogenic Shock Thought Leader At Cardiovascular Clinical Trials Conference
Express News | Windtree Announces Istaroxime Presentation by Cardiogenic Shock Thought Leader at Cardiovascular Clinical Trials Conference
Windtree Therapeutics Announces New Istaroxime Patent Filing
Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia
H.C. Wainwright Maintains Windtree Therapeutics(WINT.US) With Hold Rating
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
JusTrynaStayAbove25k : Never. Ive seen them do multiple r/s since I became a bagholder here.
Hoᛋᛋ OP : I've been holding it since winter 2019/20